• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Here's the Level to Zero In on for UnitedHealth Group

Shares of the diversified healthcare company have held up fairly well despite the decline in the broader market but soon could be put to the test.
By BRUCE KAMICH
Jun 13, 2022 | 07:29 AM EDT
Stocks quotes in this article: UNH

UnitedHealth Group Inc. ( UNH) has been in a strong uptrend for months and has resisted the downward tug of the broad markets, but that out-performance could be tested this week as prices are poised for another test of the key 200-day moving average line. 
 
Let's check the charts and indicators for UnitedHealth Group.  
 
In this daily bar chart of UNH, below, we can see that prices have trended higher the past 12 months. Notice how prices have rebounded off the rising 200-day moving average line? In early October. We get close to the line in late February and there is another test in May. The rallies off of these tests have been strong until now. The rebound from May into June stopped at the underside of the 50-day moving average line and this Monday we are likely to see another test of the 200-day line, which intersects around $468 or so. The On-Balance-Volume (OBV) line shows a rise to late May and the start of a decline in the early days of June, suggesting a shift from aggressive buying to aggressive selling. The trend-following Moving Average Convergence Divergence (MACD) oscillator turned upward in May for a cover shorts buy signal but has quickly narrowed and could cross to the downside again for a new sell signal. 
 
 
 
In this weekly Japanese candlestick chart of UNH, below, we can see a weakening picture. Prices are in a short-term downward trend and poised for a test (again) of the rising 40-week moving average line. The weekly OBV line shows a decline in April and May to test a three-year uptrend. The MACD oscillator crossed to the downside in late April for a take profit sell signal. 
 
 
In this daily Point and Figure chart of UNH, below, we can see a downside price target of $465. 
 
 
 
In this weekly Point and Figure chart of UNH, below, we can see a potential longer-term downside price objective in the $374 area. 
 
 
 
Bottom line strategy: There is an old and politically incorrect saying on the floor of the stock exchange -- "When they raid the house they take all the ladies" -- which is a crude way of saying that in a bear market no one is left unscathed. This could be the moment when UNH breaks its uptrend. Avoid the long side of UNH. A close below $468 would break the 200-day line, I believe. 
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Health Care Equipment & Services | Healthcare | Real Money

More from Stocks

Hopeful Investors Get Scraped by the Bear

James "Rev Shark" DePorre
Jun 28, 2022 4:24 PM EDT

Bulls hoped that a bottom had been found, but they overlooked the reasons behind the rally last week.

Bed Bath & Beyond's Weakness is Likely to Persist

Bruce Kamich
Jun 28, 2022 2:36 PM EDT

The shares have been in the single digits since early May.

Let's Look Under the 'Shell' of This ESG-Style Fund

Mark Abssy
Jun 28, 2022 2:00 PM EDT

One of the Nuveen Global Net-Zero Transition exchange-traded fund's largest holdings is Shell, so let's drill down on this supposedly environmentally friendly ETF.

Taking Another Look at ON Semiconductor's Charts

Bruce Kamich
Jun 28, 2022 1:43 PM EDT

Here's what to watch for.

Feeling Queasy Over Moderna's Outlook? Investors May Still Get Their Shot

Brad Ginesin
Jun 28, 2022 12:45 PM EDT

With an expected dip for 2023, the pharmaceutical company could see its mRNA technology win big over the long term -- and investors could be rewarded.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:56 AM EDT STEPHEN GUILFOYLE

    Stocks Under $10

    Check out what's going on in the Stocks Under $10 ...
  • 12:04 AM EDT PAUL PRICE

    Two Good Signs -- Especially for Small-Cap Investors

  • 12:10 AM EDT PAUL PRICE

    More Insider Buying in American Woodmark (AMWD)

    American Woodmark , which I've discussed here fr...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login